Tyzeka is a new oral antiviral for chronic hepatitis B
Tyzeka is a new oral antiviral for chronic hepatitis B.
It's an alternative to using lamivudine (Epivir-HBV)...adefovir (Hepsera)...entecavir (Baraclude)...or interferons (Pegasys, etc).
Tyzeka (telbivudine) is well-tolerated like lamivudine...but it's more effective at suppressing the hepatitis B virus.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote